Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-17

Clinical Trial Update: Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating whether glutamine supplementation reduces chemotherapy-induced toxicities in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)

Snippet

Sponsor: Banaras Hindu University | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED